GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NWBO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Northwest Biotherapeutics stock price ended at $0.510 on Thursday, after gaining 1.78%.
(Updated on Apr 18, 2024)

Sell candidate since Apr 04, 2024 Loss -6.46% PDF

The Northwest Biotherapeutics stock price gained 1.78% on the last trading day (Thursday, 18th Apr 2024), rising from $0.501 to $0.510. During the last trading day the stock fluctuated 4.85% from a day low at $0.495 to a day high of $0.519. The price has fallen in 7 of the last 10 days and is down by -6.46% for this period. Volume fell on the last day by -125 thousand shares and in total, 1 million shares were bought and sold for approximately $573.15 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.20% during the next 3 months and, with a 90% probability hold a price between $0.397 and $0.502 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NWBO Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 1.78%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Northwest Biotherapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.510 and $0.534. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Northwest Biotherapeutics stock

Northwest Biotherapeutics finds support from accumulated volume at $0.506 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0240 between high and low, or 4.85%. For the last week the stock has had daily average volatility of 5.55%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NWBO) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Northwest Biotherapeutics to open at $0.508, and during the day (based on 14 day Average True Range), to move between $0.473 and $0.547, which gives a possible trading interval of +/-$0.0372 (+/-7.30%) up or down from last closing price. If Northwest Biotherapeutics takes out the full calculated possible swing range there will be an estimated 14.59% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.506 (0.78%) than the resistance at $0.519 (1.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Northwest Biotherapeutics stock A Buy?

Northwest Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.726 Sell Candidate Unchanged

Predicted Opening Price for Northwest Biotherapeutics of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$0.508 ( 0.392%) $0.510

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NWBO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.532 4.31 %
R2 0.523 2.52 %
R1 0.517 1.41 %
Current price: 0.510
Support S1 0.499 -2.19 %
S2 0.493 -3.30 %
S3 0.484 -5.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.600 17.65 %
R2 0.550 7.84 %
R1 0.519 1.76 %
Current price 0.510
Support S1 0.506 -0.784%
S2 0.488 -4.31%
S3 0.485 -4.86%

FAQ

What is the symbol for Northwest Biotherapeutics Stock and on which exchange is it traded?
The symbol for Northwest Biotherapeutics is NWBO and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Northwest Biotherapeutics Stock?
Northwest Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Northwest Biotherapeutics Stock?
Northwest Biotherapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Northwest Biotherapeutics Stock.

What's the current price of Northwest Biotherapeutics Stock?
As of the end of day on the 2024-04-18, the price of an Northwest Biotherapeutics (NWBO) share was $0.510.

What is the 52-week high and low for Northwest Biotherapeutics Stock?
The 52-week high for Northwest Biotherapeutics Stock is $1.09 and the 52-week low is $0.400.

What is the market capitalization of Northwest Biotherapeutics Stock?
As of the 2024-04-18, the market capitalization of Northwest Biotherapeutics is 606.885M.

When is the next earnings date for Northwest Biotherapeutics?
The upcoming earnings date for Northwest Biotherapeutics is May 08, 2024.
Click to get the best stock tips daily for free!

About Northwest Biotherapeutics

Northwest Biotherapeutics Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company ... NWBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT